Patent familyBCI, high confidence
Brain-controlled body movement assistance devices and methods
Filed by Kandu, first in 2013.
- Earliest priority
- 15 Mar 2013 · United States
- Status
- A grant was published in Canada, European Patent Office, United States, first on 10 Jan 2017
- Published in
- United States · Canada · International (PCT) · Australia · European Patent Office
- Registered as
- NEUROLUTIONS, INC.
- Inventors
- Leuthardt, Eric C. · Love, Lonnie J. · Coker, Rob · Moran, Daniel W.
- Family
- DOCDB 51531369 · 20 publications
What it concerns
Methods, devices, systems, and apparatus, including computer programs encoded on a computer storage medium, for brain-controlled body movement assistance devices. In one aspect, a device includes a brain-controlled body movement assistance device with a brain-computer interface (BCI) component adapted to be mounted to a user, a body movement assistance component operably connected to the BCI component and adapted to be worn by the user, and a feedback mechanism provided in connection with at least one of the BCI component and the body movement assistance component, the feedback mechanism being configured to output information relating to a usage session of the brain-controlled body movement assistance device.
The abstract as published by the patent office, from US2014277582A1. It describes the invention; it is not a statement of what is protected.
Protection themes
Interface and electrodes
Peripheral interfaces
Decoding
Motor decoding
Stimulation
Stimulation
What the filing appears to be about, read by published rules from its title, abstract and classification codes (A61B2505/09, A61B5/0006, A61B5/282, A61B5/372, A61F2/54). The claims define what a patent protects, and they are not read here.
Why it matters
- Interface and electrodes
- Everything downstream works with what the contacts pick up. Their number, size and distance from the neurons set the ceiling on the signal. The problem behind it: more contacts, closer to neurons, that still record after years in tissue that reacts to them.
- Decoding
- This is the step that turns brain activity into a command or a word. Its accuracy and speed are what a user experiences. The problem behind it: accuracy that holds over months without frequent recalibration, for more than one user and one task.
- Stimulation
- Restoring sensation, sight or movement needs information going in, and a therapy that adapts needs to sense and stimulate at once. The problem behind it: evoking a precise, stable effect without damaging tissue or electrodes, and without blinding the recording.
Why the layer matters to the field, not a judgement of this filing. A patent family shows that protection was sought. It does not show that the technology was built, is used in a product, or works in people. The whole stack
The family
One invention, published 20 times in 5 offices. Each publication opens in Espacenet.
- United StatesUS2014277582A118 Sep 2014US9539118B210 Jan 2017 · grantUS2017119271A14 May 2017US10405764B210 Sep 2019 · grantUS2019350478A121 Nov 2019US12279976B222 Apr 2025 · grantUS20250302643A12 Oct 2025
- CanadaCA2904931A125 Sep 2014CA2904931C10 Jan 2023 · grant
- International (PCT)a route to several countries, not a countryWO2014150199A225 Sep 2014WO2014150199A314 May 2015
- AustraliaAU2014237444A124 Sep 2015AU2014237444B220 Dec 2018AU2019201914A111 Apr 2019AU2019201914B228 Jan 2021
- European Patent Officea route to several countries, not a countryEP2968908A220 Jan 2016EP2968908A412 Apr 2017EP2968908B115 Jul 2020 · grantEP3799924A17 Apr 2021EP3799924B13 Jul 2024 · grant
Timeline
- 15 Mar 2013First filingEarliest priority, at United States. The family is counted in this year.
- 17 Jan 2014Owner recordedUnited States, on US2014277582A1: assignment; owner named: NEUROLUTIONS, INC., MISSOURI.
- 10 Mar 2014ApplicationsFiled at Canada, International (PCT), Australia, European Patent Office.
- 18 Sep 2014First publicationUS2014277582A1, United States.
- 9 Jan 2017ApplicationFiled at United States.
- 19 Mar 2019ApplicationFiled at Australia.
- 30 Jul 2019ApplicationFiled at United States.
- 5 Aug 2019Owner recordedUnited States, on US2019350478A1: assignment; owner named: NEUROLUTIONS, INC., CALIFORNIA.
- 10 Jan 2023Grant publishedCA2904931C, Canada.
- 3 Jul 2024Grant publishedEP3799924B1, European Patent Office.
- 19 Mar 2025ApplicationFiled at United States.
- 22 Apr 2025Grant publishedUS12279976B2, United States.
- 9 Sep 2026Office recordEuropean Patent Office, on EP3799924A1: lapsed in a contracting state [announced via postgrant information from national office to epo] (AL, AT, BE, BG, CH, CY, CZ, DK, EE, ES, FI, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).
Dates as the offices published them. Office records are in the offices' own words and are a selection: refusals, lapses and withdrawals, and records that name an owner. Each concerns one member of the family, not the family as a whole, and another member in the same office may stand. Whether a patent is in force today is not assessed.
Sources
- Bibliographic data, family members and office records: European Patent Office, Open Patent Services (the DOCDB and INPADOC databases), read 7 Oct 2026.
- The record itself, with its claims and description: US2014277582A1 in Espacenet
- Counted as a BCI patent family: title or abstract names the field; classified A61F2/72 (bioelectric control of prostheses); filed by NEUROLUTIONS, INC., an organisation already in the graph; cites a family already accepted. How families are found and judged